Skip Navigation

HIV/AIDS

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Vaccines Reports and Articles

General Reports

News from Our Partners

Joint Venture Between CHAVI and HVTN Creates Early Career Investigators Awards Program

Center for HIV/AIDS Vaccine Immunology (CHAVI) 2008: Forging New Way Ahead

HIV Vaccine Trials Network (HVTN) 2008: Reshaped scientific agenda involves understanding the clinical and immunological aspects of the Step trial

Center for HIV/AIDS Vaccine Immunology (CHAVI) 2007: Injecting New Ideas

Meeting Reports

Microbial Agents in Animal Cell Substrates: An Update on Testing & Methods, April 20-21, 2009 (PDF)

Keystone Symposia 2009 - New Discoveries Provide Insight into Protective Immune Responses to HIV

Nonhuman Primate AIDS Vaccine Workshop, November 11-13, 2008

Keystone Symposia 2008 - Recalibration of the HIV Vaccine Field

AIDS Vaccine 2008 - New Discoveries Energize the HIV Vaccine Field

Journal Articles and Publications by DAIDS/NIAID Staff

D'Souza MP, Axten KL, Hecht FM, Altfeld M. Acute HIV-1 infection: what's new? Where are we going? J Infect Dis. 2010 Oct 15;202 Suppl 2:S267-9.

Jaimes MC, Maecker HT, Yan M, Maino VC, Hanley MB, Greer A, Darden JM, D'Souza MP. J Immunol Methods. 2010 Aug 19. Quality assurance of intracellular cytokine staining assays: Analysis of multiple rounds of proficiency testing.

Gilbert P, Wang M, Wrin T, Petropoulos C, Gurwith M, Sinangil F, D'Souza P, Rodriguez-Chavez IR, DeCamp A, Giganti M, Berman PW, Self SG, Montefiori DC. Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine. J Infect Dis. 2010 Aug 15;202(4):595-605.

Schito ML, D'Souza MP, Owen SM, Busch MP, Challenges for rapid molecular HIV diagnostics. J Infect Dis. 2010 Apr 15;201 Suppl 1:S1-6.

D'Souza MP, Frahm N., Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies. AIDS. 2010 Mar 27;24(6):803-9.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009 Dec 3;361(23):2209-20. Epub 2009 Oct 20.

Bradac J, Dieffenbach CW., HIV vaccine development: Lessons from the past, informing the future. IDrugs. 2009 Jul;12(7):435-9. Review.

Belyakov IM and Ahlers JD. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol Med. May 30, 2009 epub.

Flores J. Seeking new pathways for HIV vaccine discovery. Future Microbiol. 4: 1, 2009.

Belyakov IM and Ahlers JD. Functional CD8(+) CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine. Trends Immunol. Oct 4, 2008 epub.

Girard MP and Bansal GP. HIV/AIDS vaccines: a need for new concepts? Int Rev Immunol. 27 (6): 447, 2008.

Girard MP, Bansal GP, Pedroza-Martins L, Dodet B, Mehra V, Schito M, Mathieson B, Delfraissy JF, Bradac J. Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007. Vaccine. 26 (32): 3969, 2008.

Johnston MI and Fauci AS. An HIV Vaccine--Challenges and Prospects. N Engl J Med. 359 (9): 888, 2008.

Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC. HIV Vaccine Research: The Way Forward. Science. 321 (5888): 530, 2008.

Shattock RJ, Haynes BF, Pulendran B, Flores J, Esparza J; on behalf of a Working Group convened by the Global HIV Vaccine Enterprise. Improving Defences at the Portal of HIV Entry: Mucosal and Innate Immunity. PLoS Med. 5 (4): e81, 2008

Lau CY, Cardinali M, Sato PA, Fix A, Flores J. Broadening Inclusion of Vulnerable Populations in HIV Vaccine Trials. Expert Rev Vaccines. 7 (2): 259-268, 2008.

Allen M, Lau CY. Social Impact of Preventive HIV Vaccine Clinical Trial Participation: A model of Prevention, Assessment and Intervention. Soc Sci Med. 66 (4): 945-951, 2008.

D'Souza MP, Altfeld M. Measuring HIV-1-Specific T Cell Immunity: How Valid Are Current Assays? J Infect Dis. 197 (3): 337-339, 2008.

Ezzelle J, Rodriguez-Chavez IR, Darden JM, Stirewalt M, Kunwar N, Hitchcock R, Walter T, D'Souza MP. Guidelines on Good Clinical Laboratory Practice: Bridging Operations between Research and Clinical Research Laboratories. J Pharm Biomed Anal. 46 (1): 18-29, 2008.

back to top

 

Last Updated December 13, 2010